Affinity-Asset-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
91
Total Value
976714470
Accession Number
0001999371-25-006074
Form Type
13F-HR
Manager Name
Affinity-Asset-Advisors
Data Enrichment
86% identified
78 identified13 unidentified

Holdings

91 positions
Manager:
Search and click to pin securities to the top
ESTABLISHMENT LABS HOLDINGS INC.
Shares:280.0K
Value:$11.4M
INSMED Inc
Shares:140.0K
Value:$10.7M
BridgeBio Pharma, Inc.
Shares:300.0K
Value:$10.4M
Nurix Therapeutics, Inc.
Shares:810.7K
Value:$9.6M
Protagonist Therapeutics, Inc
Shares:172.5K
Value:$8.3M
CORCEPT THERAPEUTICS INC
Shares:70.0K
Value:$8.0M
Trevi Therapeutics, Inc.
Shares:1.3M
Value:$7.9M
Spyre Therapeutics, Inc.
Shares:481.7K
Value:$7.8M
Immunovant, Inc.
Shares:430.0K
Value:$7.3M
89422GAA5
Shares:
Value:$7.0M
Vera Therapeutics, Inc.
Shares:265.0K
Value:$6.4M
Oruka Therapeutics, Inc.
Shares:545.4K
Value:$5.6M
NEUROCRINE BIOSCIENCES INC
Shares:50.0K
Value:$5.5M
Avalo Therapeutics, Inc.
Shares:657.2K
Value:$5.3M
Viridian Therapeutics, Inc.\DE
Shares:390.0K
Value:$5.3M
Lexeo Therapeutics, Inc.
Shares:1.5M
Value:$5.1M
Crinetics Pharmaceuticals, Inc.
Shares:152.3K
Value:$5.1M
EXELIXIS, INC.
Shares:135.0K
Value:$5.0M
Rezolute, Inc.
Shares:1.7M
Value:$4.9M
Perspective Therapeutics, Inc.
Shares:2.2M
Value:$4.7M